The emerging treatment of the medication represents a major development in the handling of type 2 diabetes. Distinct from existing medications, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide022569.win-blog.com/23402679/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment